FIELD: organic chemistry, medicine, chemical-pharmaceutical industry, pharmacy. SUBSTANCE: invention relates to a therapeutic agent used for treatment of spinal channel stenosis and comprising 4-bromo-6-[3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino)-3(2H)-pyridazinone taken in the effective dose. The agent shows the enhanced activity. EFFECT: valuable medicinal properties of agent. 3 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PREVENTER OF BLOOD VESSELS INTIMA HYPERPLASIA | 2005 |
|
RU2339381C2 |
| ANTINEUTROPHILIC AGENT | 2004 |
|
RU2356555C2 |
| DERIVATIVES OF 3(2H)-PYRIDAZINONE AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION ON THEIR BASE | 1991 |
|
RU2054004C1 |
| DERIVATIVES OF 3(2H)-PYRIDAZINONES OR THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND PHARMACEUTICAL COMPOSITION ON SAID | 1994 |
|
RU2138486C1 |
| AGENT FOR TREATMENT OF ERECTILE FUNCTION | 1999 |
|
RU2229885C2 |
| METHOD OF PRODUCING DERIVATIVES OF 3(2N)-PYRIDAZINONE | 0 |
|
SU1584750A3 |
| METHOD OF PRODUCING DERIVATIVES OF 3(2H)PYRIDAZINONE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 0 |
|
SU1468415A3 |
| METHOD OF OBTAINING DERIVATIVES OF 3(2H) PYRIDAZINON | 0 |
|
SU1577696A3 |
| AGENT PROMOTING PRODUCTION/SECRETION OF NEUROTROPHINE COMPRISING AZOLE DERIVATIVE, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT BASED ON THEREOF | 2000 |
|
RU2260003C2 |
| PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2198682C2 |
